---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011461"
form_type: "8-K"
ticker: null
cik: "0001261249"
company_name: "AGILE THERAPEUTICS INC"
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:02:59.596638+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Agile Therapeutics appoints Scott Coiante as SVP, CFO; CAO Jason Butch to depart

## Summary
- Scott Coiante appointed SVP, CFO and Treasurer effective Aug 16, 2023; he previously served as Agile's CFO from 2010-2019.
- Jason Butch to separate as Chief Accounting Officer on Aug 15, 2023 by mutual agreement.
- Butch to receive 6 months base salary and health care subsidies as severance, subject to signing release.
- Coiante most recently CFO of Aprea Therapeutics; prior roles at Medarex and Ernst & Young.
- No family relationships or material interests between Coiante and any director or officer.

## SEC filing metadata
- accession: 0001558370-23-011461
- form_type: 8-K
- cik: 0001261249
- company_name: AGILE THERAPEUTICS INC
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/agrx-20230621x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011461
- JSON: https://secwatch.observer/filing/0001558370-23-011461.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011461.txt

## Key facts
- Executive change
  Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.
  - Action: separate from service
  - Role: Chief Accounting Officer
  source text: the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch will separate from service as the Chief Accounting Officer, effective August 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm
- Executive change
  Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer and Treasurer
  source text: the Board of Directors of Agile Therapeutics, Inc. (the “Company”) appointed Scott Coiante to serve as Senior Vice President. Chief Financial Officer and Treasurer, effective August 16, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.